Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 May 27;83(2):e33-e38.
doi: 10.1055/s-0042-1749389. eCollection 2022 Apr.

Silent Corticotroph and Somatotroph Double Pituitary Adenoma: A Case Report and Review of Literature

Affiliations
Case Reports

Silent Corticotroph and Somatotroph Double Pituitary Adenoma: A Case Report and Review of Literature

Isabella L Pecorari et al. J Neurol Surg Rep. .

Abstract

Clinically silent double pituitary adenomas consisting of corticotroph and somatotroph cells are an exceedingly rare clinical finding. In this report, we present the case of a 28-year-old man with a 1-year history of recurrent headaches. Imaging revealed a 2.1 (anterior-posterior) × 2.2 (transverse) × 1.3 (craniocaudal) cm pituitary adenoma invading into the left cavernous sinus and encasing the left internal carotid artery. Endoscopic transnasal resection was performed without complications. Immunohistochemical staining revealed a double adenoma consisting of distinct sparsely granulated somatotroph and densely granulated corticotroph cells that were positive for growth hormone and adrenocorticotropic hormone, respectively. K i -67 index labeling revealed a level of 6% within the corticotroph adenoma. No increase in serum growth hormone or adrenocorticotropic hormone was found, indicating a clinically silent double adenoma. While transsphenoidal surgery remains a first-line approach for silent adenomas presenting with mass effects, increased rates of proliferative markers, such as the K i -67 index, provide useful insight into the clinical course of such tumors. Determining the K i -67 index of silent pituitary adenomas could be valuable in predicting recurrence after initial surgical resection and identifying tumors that are at an increased risk of needing additional therapeutic interventions or more frequent surveillance imaging.

Keywords: K i -67; corticotroph; double pituitary adenoma; somatotroph.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

Figures

Fig. 1
Fig. 1
Coronal T2-weighted contrast-enhanced magnetic resonance imaging (MRI) showing pituitary gland enlargement with resultant stalk deviation (arrowhead) and encasement of the internal carotid artery (arrow).
Fig. 2
Fig. 2
The corticotroph adenoma (left) shows diffuse cytoplasmic staining with CAM5.2 while the somatotroph tumor (right) shows distinctive fibrous body type staining.
Fig. 3
Fig. 3
K i -67 proliferative index is elevated in the corticotroph adenoma (∼6%; left) and lower in the somatotroph adenoma (∼1%; right).

Similar articles

Cited by

References

    1. Drummond J, Roncaroli F, Grossman A B, Korbonits M. Clinical and pathological aspects of silent pituitary adenomas. J Clin Endocrinol Metab. 2019;104(07):2473–2489. - PMC - PubMed
    1. Mayson S E, Snyder P J. Silent (clinically nonfunctioning) pituitary adenomas. J Neurooncol. 2014;117(03):429–436. - PubMed
    1. Larkin S, Ansorge O.Pathology and Pathogenesis of Pituitary Adenomas and Other Sellar LesionsPubMed; 2000. Accessed November 11, 2021 at:https://www.ncbi.nlm.nih.gov/books/NBK425704/
    1. Cooper O, Melmed S. Subclinical hyperfunctioning pituitary adenomas: the silent tumors. Best Pract Res Clin Endocrinol Metab. 2012;26(04):447–460. - PMC - PubMed
    1. Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev. 2001;22(06):724–763. - PubMed

Publication types